We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Industry Asks FDA for Clarity in Natural Histories for Rare Disease Trials
Drug Industry Asks FDA for Clarity in Natural Histories for Rare Disease Trials
The drug industry is asking the FDA for more clarity around whether or not natural histories should be included in rare disease trials—and two of the nation’s largest drug trade groups appear to be at odds over the issue.